Status:
TERMINATED
The Impact of a Preoperative Nerve Block on the Consumption of Sevoflurane in Total Shoulder Arthroplasty
Lead Sponsor:
University of Alberta
Conditions:
Rotator Cuff Injuries
Anesthesia; Functional
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
Total arthroplasty surgery of the shoulder is performed under general anesthesia. Pain control for after the surgery can be achieved purely with intravenous and oral pain medication or in combination ...
Detailed Description
Following ethics approval, eligible patients meeting the inclusion/exclusion criteria will be consented in pre-assessment unit or day surgery ward at least 2 hours prior to their surgery. Patients wil...
Eligibility Criteria
Inclusion
- Patients undergoing elective shoulder arthroscopy
- Patients eligible for interscalene brachial plexus block
- All adults 18 years of age or older
- Capable to give consent
Exclusion
- Patients who are unable to give consent
- Local anaesthetic allergy
- Hemidiaphragm paresis on the contralateral side to the block/surgery site
- Bleeding diathesis
- Coagulopathy
- Pre-existing neurological deficits
- Patients with a Body Mass Index \>35
- Patients with significant comorbidities, physiological limitations, and allergies that are unable to tolerate the protocolized induction and maintenance of anesthesia.
Key Trial Info
Start Date :
August 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 15 2020
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT04020601
Start Date
August 1 2019
End Date
March 15 2020
Last Update
June 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alberta Hospital
Edmonton, Alberta, Canada, T6G2G3